What drives the price gap between regular and encapsulated salicylic acid in China?

The price spread between commodity salicylic acid and encapsulated or supramolecular grades is widening, driven by downstream cosmetics formulators willing to pay for reduced irritation. Standard salicylic acid is cheap and widely produced via the Kolbe-Schmitt process, but its low pH (around 2.4) and fast release cause stinging, redness, and peeling. Encapsulated versions—using poloxamer 407 or similar carriers—release the active gradually over up to 12 hours, cutting irritation while maintaining efficacy. This technology commands a significant premium. For buyers, the choice is not just about price per kilogram but about formulation cost and consumer compliance. Products with 2.5% encapsulated salicylic acid are positioned as the sweet spot between efficacy and gentleness, and this positioning supports higher retail prices and, in turn, higher raw-material costs.